Erratum: Superimmunity by pan-sarbecovirus nanobodies (Cell Reports (2022) 39(13), (S2211124722007938), (10.1016/j.celrep.2022.111004))

  • Yufei Xiang
  • , Wei Huang
  • , Hejun Liu
  • , Zhe Sang
  • , Sham Nambulli
  • , Jérome Tubiana
  • , Kevin L. Williams
  • , W. Paul Duprex
  • , Dina Schneidman-Duhovny
  • , Ian A. Wilson
  • , Derek J. Taylor
  • , Yi Shi*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

(Cell Reports 39, 111004; June 28, 2022) As this paper was originally published on June 23, 2022, it mistakenly included the NIH grant RM1GM142002 as a funding source. The authors apologize for the error.

Original languageEnglish
Article number116023
JournalCell Reports
Volume44
Issue number7
DOIs
StatePublished - 22 Jul 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum: Superimmunity by pan-sarbecovirus nanobodies (Cell Reports (2022) 39(13), (S2211124722007938), (10.1016/j.celrep.2022.111004))'. Together they form a unique fingerprint.

Cite this